Compare XBIT & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | ICG |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | China |
| Employees | N/A | 127 |
| Industry | Pharmaceuticals and Biotechnology | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.0M | 69.2M |
| IPO Year | 2015 | 2022 |
| Metric | XBIT | ICG |
|---|---|---|
| Price | $2.41 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.25 |
| AVG Volume (30 Days) | 21.3K | ★ 67.1K |
| Earning Date | 05-08-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $0.93 |
| 52 Week High | $3.61 | $3.22 |
| Indicator | XBIT | ICG |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 35.24 |
| Support Level | $2.35 | $0.93 |
| Resistance Level | $2.41 | $1.36 |
| Average True Range (ATR) | 0.06 | 0.10 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 4.00 | 10.00 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.